Canada's Decision To Make Public More Clinical Trial Data Puts Pressure On FDA
Anything measured improves. The more data and metrics, the better safety of drugs can be observed. It is always a good thing to get more insight and information to help harm reduction and safety.<p>> <i>Transparency advocates say clinical study reports need to be made public in order to understand how regulators make decisions and to independently assess the safety and efficacy of a drug or device. They also say the reports provide medical societies with more thorough data to establish guidelines for a treatment's use, and to determine whether articles about clinical trials published in medical journals — a key source of information for clinicians and medical societies — are accurate.</i><p>There really is no reason why this data should not be more public at the FDA. Transparency improves safety, and that is their stated mission.<p>> FDA Mission<p>> The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation